Ckd Bio (063160) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.006x

Based on the latest financial reports, Ckd Bio (063160) has a cash flow conversion efficiency ratio of 0.006x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩771.88 Million ≈ $523.10K USD) by net assets (₩125.00 Billion ≈ $84.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Ckd Bio to measure how many days the company can operate on defensive assets alone.

Ckd Bio - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Ckd Bio's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Ckd Bio Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ckd Bio ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Lokesh Machines Limited NSE:LOKESHMACH	-0.077x
RSUPPORT Co. Ltd KQ:131370	0.000x
Ni Steel KO:008260	0.075x
Sypris Solutions Inc NASDAQ:SYPR	-0.063x
Genie Music Corporation KQ:043610	0.050x
Lion Finance Group PLC LSE:BGEO	0.071x
CUE Energy Resources Ltd AU:CUE	0.154x
Yenher Holdings Bhd KLSE:5300	0.028x

Annual Cash Flow Conversion Efficiency for Ckd Bio (2008–2025)

The table below shows the annual cash flow conversion efficiency of Ckd Bio from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Ckd Bio.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩127.04 Billion ≈ $86.09 Million	₩-4.14 Billion ≈ $-2.81 Million	-0.033x	-130.45%
2024-12-31	₩131.01 Billion ≈ $88.78 Million	₩14.03 Billion ≈ $9.51 Million	0.107x	+282.39%
2023-12-31	₩123.02 Billion ≈ $83.37 Million	₩-7.22 Billion ≈ $-4.90 Million	-0.059x	-170.82%
2022-12-31	₩147.80 Billion ≈ $100.16 Million	₩-3.20 Billion ≈ $-2.17 Million	-0.022x	+40.47%
2021-12-31	₩161.49 Billion ≈ $109.44 Million	₩-5.88 Billion ≈ $-3.99 Million	-0.036x	-227.41%
2020-12-31	₩168.75 Billion ≈ $114.36 Million	₩4.82 Billion ≈ $3.27 Million	0.029x	-73.34%
2019-12-31	₩158.46 Billion ≈ $107.39 Million	₩16.99 Billion ≈ $11.51 Million	0.107x	+1.91%
2018-12-31	₩147.66 Billion ≈ $100.07 Million	₩15.54 Billion ≈ $10.53 Million	0.105x	-26.90%
2017-12-31	₩142.05 Billion ≈ $96.26 Million	₩20.45 Billion ≈ $13.86 Million	0.144x	+25.52%
2016-12-31	₩135.16 Billion ≈ $91.60 Million	₩15.50 Billion ≈ $10.50 Million	0.115x	+1.87%
2015-12-31	₩127.38 Billion ≈ $86.32 Million	₩14.34 Billion ≈ $9.72 Million	0.113x	+22.22%
2014-12-31	₩121.85 Billion ≈ $82.57 Million	₩11.22 Billion ≈ $7.61 Million	0.092x	+4.45%
2013-12-31	₩123.87 Billion ≈ $83.95 Million	₩10.92 Billion ≈ $7.40 Million	0.088x	-52.19%
2012-12-31	₩124.15 Billion ≈ $84.13 Million	₩22.90 Billion ≈ $15.52 Million	0.184x	+69.33%
2011-12-31	₩119.00 Billion ≈ $80.65 Million	₩12.96 Billion ≈ $8.79 Million	0.109x	-65.28%
2010-12-31	₩76.14 Billion ≈ $51.60 Million	₩23.89 Billion ≈ $16.19 Million	0.314x	-24.35%
2009-12-31	₩64.08 Billion ≈ $43.42 Million	₩26.57 Billion ≈ $18.01 Million	0.415x	+90.70%
2008-12-31	₩49.15 Billion ≈ $33.31 Million	₩10.69 Billion ≈ $7.24 Million	0.217x	--

About Ckd Bio

KO:063160 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$59.56 Million

₩87.89 Billion KRW

Market Cap Rank

#21277 Global

#1230 in Korea

Share Price

₩16020.00

Change (1 day)

+0.69%

52-Week Range

₩15200.00 - ₩24500.00

All Time High

₩101057.67